Fundraising Fox
Alkeuspharma
Cambridge, US · Founded 2010 · 57 employees on LinkedIn · 4 known investors
Find your way into Alkeuspharma
Sign up to see every warm intro you have to Alkeuspharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Alkeuspharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Alkeus Pharma develops therapies for retinal diseases, including inherited and neovascular conditions. The company focuses on gene therapies and other advanced treatment modalities for ophthalmology.
Founders & leadership
CQ
Carlos Quezada-RuizChief Medical OfficerCarlos Quezada-Ruiz is a retina specialist and physician-scientist with over 15 years of clinical and drug development experience in ophthalmology, including leadership roles at Genentech/Roche and 4D Molecular Therapeutics spanning biologics, sustained drug delivery, gene therapy, and inherited retinal diseases. He serves as Chief Medical Officer at Alkeus Pharmaceuticals, which develops therapies for retinal diseases.
Investors · 4
Bain Capital Life Scienceslisted by Bain Capital Life SciencesBoston
How we know: Bain Capital Life Sciences's portfolio page · Not right? Tell us
Sofinnova Ventureslisted by Sofinnova VenturesMenlo Park · $100K – $15M
How we know: Sofinnova Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Wellington Managementlisted by Wellington ManagementBoston · $5M – $50M
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
Frequently asked questions
- What does Alkeuspharma do?
- Alkeus Pharma develops therapies for retinal diseases, including inherited and neovascular conditions. The company focuses on gene therapies and other advanced treatment modalities for ophthalmology.
- Who are Alkeuspharma's investors?
- Alkeuspharma's investors include Bain Capital Life Sciences, Sofinnova Ventures, TCG Crossover, Wellington Management.
- Where is Alkeuspharma headquartered?
- Alkeuspharma is headquartered in Cambridge, US.